BMS-562086

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-562086, covering 2008-09-26 to 2010-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder [Phase 1, Phase 2]